Skip to Content

Logo (Actavis) 271 (Morphine Sulfate Extended-Release 30 mg)

Pill with imprint Logo (Actavis) 271 is Yellow, Round and has been identified as Morphine Sulfate Extended-Release 30 mg. It is supplied by Actavis Pharma, Inc..

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for Logo (Actavis) 271

Morphine Sulfate Extended-Release

Imprint
Logo (Actavis) 271
Strength
30 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00228-4271
Inactive Ingredients
lactose anhydrous, magnesium stearate, magnesium silicate, titanium dioxide, ferric oxide yellow, polyethylene glycol, cetostearyl alcohol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.